Bal Pharma Share Price
NSE: BALPHARMA
₹ 88.50
-₹2.00 (-2.21%)
1D
Last updated 13 Aug, 2026, 15:29 IST
₹86.32
2.21% down today
₹89.00
1D LOW1D HIGH
Latest Earning
Op Profit TrendUp by 79.89% QoQLatest Earning
Net Profit TrendUp by 101.12% QoQLatest Earning
Revenue TrendUp by 2.72% YoYStock Performance
OutperformingBeat Nifty by 13.38 % in last 1 monthShareholding Pattern
FIIFII increased stake by 8.86%Bal Pharma Returns Calculator
If you would've invested
₹
₹1,000₹1Cr
Historical Returns
1 Year
₹5,02,277+₹2,277 (+0.46%)
3 Year
₹4,51,818-₹48,182 (-9.64%)
5 Year
₹4,48,830-₹51,170 (-10.23%)
Market Overview
About
Fundamentals
Financials
Technicals
Events
FAQs
Open
₹88.25
High
₹89.00
Low
₹86.32
Prev. close
₹90.50
Volume
24,327
Average traded price
₹87.80
Last traded time
03:29:15 13 Aug
Last traded quantity
300
₹70.60₹105.88
Circuit LowCircuit High
₹60.00₹98.85
52-Week Low52-Week High
Circuit
LH
₹70.60
₹105.88
52-week
LH
₹60.00
₹98.85
About Bal Pharma
ISIN
Sector Market Cap
Bal Pharma Limited is a pharmaceutical company engaged in the manufacturing and selling of pharmaceutical products. The Company is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). It specializes in prescription drugs, generic & OTC products, intravenous infusion, and bulk actives. The Company offers a range of APIs including antihistamine, platelet inhibitor, anti-diabetic, anticonvulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, and others. It also offers a range of formulations covering dosage forms-tablets, capsules, syrups, suspensions, IV infusions, ophthalmics, creams and ointments to various semi-regulated markets. The API products are being exported to Japan, Australia, Spain, the United Kingdom, Canada, Nigeria, Iceland, Slovenia, Romania, Brazil, Pakistan, Germany, South Africa, Serbia, Taiwan, Malaysia, Thailand, among others.
Bal Pharma Financial Highlights
- Revenue: Bal Pharma reported revenue of ₹313.59 crore in FY26 vs ₹305.28 crore in FY25. It showed an increase of 2.72% on a yearly basis.
- Operating Profit: Bal Pharma reported an operating profit of ₹5.93 crore in FY26 vs ₹5.14 crore in FY25. It showed an increase of 15.37% on a year-on-year basis.
- Net Profit: Bal Pharma reported a net profit of ₹6.32 crore in FY26 vs ₹7.24 crore in FY25. It showed a decrease of 12.71% on a yearly basis.
Bal Pharma Quarterly Result Highlights
- Bal Pharma reported revenue of ₹83.84 crore in Mar 2026, compared with ₹88.02 crore in Dec 2025, representing a decrease of 4.75% on a quarter-on-quarter (QoQ) basis.
- Bal Pharma reported an operating profit of ₹3.22 crore in Mar 2026, compared with ₹1.79 crore in Dec 2025, representing an increase of 79.89% on a quarter-on-quarter (QoQ) basis.
- Bal Pharma reported a profit of ₹3.60 crore in Mar 2026, compared with ₹1.79 crore in Dec 2025, reflecting an increase of 101.12% on a QoQ basis.
- The earnings per share (EPS) of Bal Pharma stood at ₹4.54 during Mar 2026.
Promoters
50.86%
FII
0.15%
Other DII
0.00%
Retail and other
48.99%
Mutual funds
0.00%
Foreign institutions - FII
| Sep 2025 | 0.22% |
|---|---|
| Dec 2025 | 0.14% |
| Mar 2026 | 0.14% |
| Jun 2026 | 0.15% |
Bal Pharma Shareholder Returns
1 day
-2.50%
1 week
+1.55%
1 month
+11.46%
1 year
-3.26%
3 years
-7.89%
5 years
-14.66%
Bal Pharma Share Price History
Day
Open / Close
Change %
13 Aug 26
₹88.25 / ₹88.24
-2.50%
12 Aug 26
₹87.90 / ₹90.50
+4.03%
11 Aug 26
₹91.80 / ₹86.99
-4.30%
10 Aug 26
₹89.45 / ₹90.90
+1.87%
07 Aug 26
₹88.02 / ₹89.23
+2.69%
06 Aug 26
₹89.00 / ₹86.89
-2.40%
05 Aug 26
₹87.55 / ₹89.03
+1.32%
04 Aug 26
₹89.49 / ₹87.87
-1.81%
03 Aug 26
₹88.40 / ₹89.49
+1.59%
31 Jul 26
₹88.34 / ₹88.09
+0.22%
Show more
Mkt Cap Cr
—
P/E
22.48
P/B
1.73
ROE
7.64%
D/E
1.48
ROCE
9.18%
Div. Yield
1.37%
EPS(TTM)
4.51
Turnover
0.85
EV/EBITDA
8.60
Net Margin
0.00%
Op. Margin
0.00%
ROA
1.68%
Quick Ratio
0.00
Curr. Ratio
2.27
Mkt Cap Cr
—
P/E
22.48
P/B
1.73
ROE
7.64%
D/E
1.48
ROCE
9.18%
Div. Yield
1.37%
EPS(TTM)
4.51
Turnover
0.85
EV/EBITDA
8.60
Net Margin
0.00%
Op. Margin
0.00%
ROA
1.68%
Quick Ratio
0.00
Curr. Ratio
2.27
Based on fundamentals, this stock's
5/5
Performance
Excellent
Bal Pharma outperforming all market indices
1/5
Valuation
Overvalued
Bal Pharma appears overvalued compared to its peers
4/5
Earnings
Good
Bal Pharma revenue, operating profit and net profit are growing
Peer Comparison
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,64,271.00 | 38.32 | 5.56 | 13.74% | 0.61 | 17.33% | 93.24 | 0.83% | 0.48 | 10.90 |
| Divis Laboratories | 2,26,843.00 | 77.55 | 13.53 | 15.32% | 0.00 | 19.56% | 629.49 | 0.35% | 0.55 | 98.19 |
| Torrent Pharmaceuticals | 1,86,000.00 | 86.27 | 22.12 | 25.49% | 1.69 | 13.85% | 222.76 | 0.69% | 0.49 | 58.70 |
| Zydus Lifesciences | 1,20,099.00 | 26.15 | 4.43 | 18.59% | 0.31 | 17.35% | 237.30 | 0.08% | 0.33 | 35.38 |
| Cipla | 1,18,027.00 | 35.18 | 3.43 | 11.27% | 0.00 | 14.95% | 423.36 | 0.89% | 0.45 | 43.52 |
| Lupin | 1,03,549.00 | 18.62 | 4.61 | 23.76% | 0.04 | 24.88% | 659.05 | 0.79% | 0.57 | 129.18 |
| Mankind Pharma | 1,00,137.00 | 48.43 | 6.14 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.44 | 49.37 |
| Dr. Reddy's Laboratories | 1,00,662.00 | 31.62 | 2.64 | 11.07% | 0.18 | 12.54% | 377.96 | 0.67% | 0.41 | 38.68 |
| Laurus Labs | 99,474.20 | 91.23 | 18.77 | 16.77% | 0.40 | 16.14% | 97.20 | 0.11% | 0.67 | 13.72 |
| Aurobindo Pharma | 96,700.60 | 26.06 | 2.55 | 9.25% | 0.19 | 11.76% | 391.14 | 0.24% | 0.38 | 41.58 |
Bal Pharma Financials
Full statement
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹303.08 | ₹339.22 | ₹304.22 | ₹281.21 |
| Other Income | ₹2.20 | ₹2.85 | ₹0.94 | ₹5.15 |
| Total Revenue | ₹305.29 | ₹342.07 | ₹305.16 | ₹286.37 |
| Total Expenses | ₹300.15 | ₹333.02 | ₹300.41 | ₹277.18 |
| Profit Before Tax | ₹5.14 | ₹9.05 | ₹4.75 | ₹9.18 |
| Tax | -₹2.10 | ₹1.60 | ₹2.13 | ₹3.48 |
| Profit After Tax | ₹7.24 | ₹7.45 | ₹2.62 | ₹5.70 |
| EPS - Basic | ₹4.54 | ₹4.96 | ₹1.67 | ₹3.79 |
| EPS - Diluted | ₹4.54 | ₹4.96 | ₹1.68 | ₹3.79 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹5.14 | ₹9.05 | ₹4.75 | ₹9.18 |
| Income before WC changes | ₹29.88 | ₹31.39 | ₹26.49 | ₹26.34 |
| Change in Assets | -₹11.84 | -₹3.06 | -₹65.63 | -₹21.12 |
| Change in Liabilities | ₹4.35 | -₹0.98 | ₹38.11 | ₹22.78 |
| Change in WC | -₹7.49 | -₹4.04 | -₹27.53 | ₹1.66 |
| Cash flow from Operations | ₹20.32 | ₹22.81 | -₹1.54 | ₹26.80 |
| Cash flow from Investing | -₹14.92 | -₹18.89 | -₹22.18 | -₹9.48 |
| Cash flow from Financing | -₹7.84 | -₹1.21 | ₹24.09 | -₹17.22 |
| Total Cash Flow | -₹2.44 | ₹2.71 | ₹0.37 | ₹0.09 |
| Cash (Start of the year) | ₹4.20 | ₹1.49 | ₹1.11 | ₹1.02 |
| Cash (End of the year) | ₹1.75 | ₹4.20 | ₹1.49 | ₹1.11 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹100.82 | ₹85.68 | ₹85.02 | ₹75.96 |
| Current Assets | ₹234.87 | ₹234.16 | ₹228.16 | ₹184.57 |
| Total Assets | ₹335.69 | ₹319.84 | ₹313.17 | ₹260.53 |
| Current Liabilities | ₹219.50 | ₹203.06 | ₹209.33 | ₹165.64 |
| Net Current Asset | ₹15.37 | ₹31.10 | ₹18.82 | ₹18.93 |
| Non-Current Liabilities | ₹38.79 | ₹44.81 | ₹40.14 | ₹36.40 |
| Equity Capital | ₹77.40 | ₹71.97 | ₹63.70 | ₹58.49 |
| Total Equity & Liabilities | ₹335.69 | ₹319.84 | ₹313.17 | ₹260.53 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹302.50 | ₹338.54 | ₹303.10 | ₹280.37 |
| Other Income | ₹2.15 | ₹2.30 | ₹2.19 | ₹6.49 |
| Total Revenue | ₹304.65 | ₹340.84 | ₹305.29 | ₹286.86 |
| Total Expenses | ₹298.91 | ₹331.52 | ₹296.74 | ₹274.80 |
| Profit Before Tax | ₹5.73 | ₹9.32 | ₹8.55 | ₹12.06 |
| Tax | -₹2.07 | ₹1.59 | ₹2.42 | ₹3.48 |
| Profit After Tax | ₹7.80 | ₹7.73 | ₹6.13 | ₹8.58 |
| EPS - Basic | ₹4.89 | ₹5.13 | ₹3.90 | ₹5.79 |
| EPS - Diluted | ₹4.89 | ₹5.13 | ₹3.94 | ₹5.67 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹5.73 | ₹9.32 | ₹8.55 | ₹12.06 |
| Income before WC changes | ₹30.34 | ₹30.85 | ₹27.40 | ₹26.04 |
| Change in Assets | -₹12.58 | ₹2.56 | -₹42.56 | -₹21.43 |
| Change in Liabilities | ₹4.63 | -₹0.32 | ₹21.04 | ₹27.07 |
| Change in WC | -₹7.95 | ₹2.23 | -₹21.52 | ₹5.64 |
| Cash flow from Operations | ₹20.31 | ₹28.54 | ₹5.38 | ₹30.57 |
| Cash flow from Investing | -₹14.90 | -₹18.84 | -₹22.08 | -₹13.43 |
| Cash flow from Financing | -₹7.83 | -₹6.94 | ₹17.12 | -₹17.22 |
| Total Cash Flow | -₹2.42 | ₹2.76 | ₹0.42 | -₹0.08 |
| Cash (Start of the year) | ₹4.06 | ₹1.30 | ₹0.81 | ₹0.89 |
| Cash (End of the year) | ₹1.64 | ₹4.06 | ₹1.23 | ₹0.81 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹102.91 | ₹87.68 | ₹77.75 | ₹71.56 |
| Current Assets | ₹247.65 | ₹246.55 | ₹269.95 | ₹218.20 |
| Total Assets | ₹350.56 | ₹334.23 | ₹347.70 | ₹289.76 |
| Current Liabilities | ₹213.46 | ₹197.13 | ₹212.15 | ₹166.10 |
| Net Current Asset | ₹34.19 | ₹49.41 | ₹57.80 | ₹52.10 |
| Non-Current Liabilities | ₹38.28 | ₹44.25 | ₹39.52 | ₹36.34 |
| Equity Capital | ₹98.82 | ₹92.84 | ₹96.03 | ₹87.32 |
| Total Equity & Liabilities | ₹350.56 | ₹334.23 | ₹347.70 | ₹289.76 |
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
88.24
10
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 10
Buy orders: 0%
Sell orders: 100%
30 levels of bid & ask depth
Supply & Demand Zones
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts available for this stock
Earn more using advisory
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
52.42
Neutral
ATR (14)
3.57
Neutral
STOCH(9,6)
35.34
Neutral
STOCH RSI (14)
25.07
Neutral
ADX(9)
31.41
Bearish
UO(9)
46.87
Neutral
ROC(12)
1.15
Bullish
WillR(14)
-64.66
Neutral
Period
Simple value
Exponential vaue
5D
89.22
88.94
10D
88.75
88.69
20D
88.5
87.87
50D
85.67
85.66
100D
81.36
82.61
| 13 Aug | 0L |
|---|---|
| 12 Aug | 0L |
| 11 Aug | 0L |
| 10 Aug | 0L |
| 7 Aug | 0L |
| Average | 0L |
Compare against other stocks
Bal Pharma
Add Stock
Add Another
Ex-date: 18 Sep 2025
₹1.2/share
Top Gainers
Popular Stocks
Tata Power Share Price
TATAPOWER
₹382.80
+3.35 (0.88%)
Tata Motors Share Price
TMPV
₹349.60
+6.60 (1.92%)
Tata Steel Share Price
TATASTEEL
₹184.85
-1.35 (-0.73%)
YES Bank Share Price
YESBANK
₹22.98
+0.00 (0.00%)
Suzlon Energy Share Price
SUZLON
₹47.61
+0.26 (0.55%)
Vodafone Idea Share Price
IDEA
₹13.51
+0.01 (0.07%)
IRFC Share Price
IRFC
₹88.35
+0.09 (0.10%)
ITC Share Price
ITC
₹278.50
+2.35 (0.85%)
Jaiprakash Power Ventures Share Price
JPPOWER
₹17.54
-0.19 (-1.07%)
Trident Share Price
TRIDENT
₹24.66
+0.00 (0.00%)
Bal Pharma Share Price FAQs
What is Bal Pharma share price today?
Bal Pharma share price is ₹88.50 as on 13 Aug, 2026, 15:29 IST.
How has the Bal Pharma share price performed in the past?
In the last 1 year, Bal Pharma delivered a return of -3.26%. The Bal Pharma share price hit a high of ₹98.85 and low of ₹60.00.
How much is the Mutual Fund shareholding in Bal Pharma shares?
The Mutual Fund Shareholding in Bal Pharma was 0.00% at the end of Jun 2026.
What is the the 52-week high and low of Bal Pharma shares ?
The 52-week high and low of Bal Pharma share is ₹98.85 and ₹60.00 as of 13 Aug, 2026.
What is the market cap of Bal Pharma?
The market capitalisation of Bal Pharma is ₹0.00 Crores as on 13 Aug, 2026.
What are the stock symbols of Bal Pharma?
The stock symbol of Bal Pharma is BALPHARMA on the NSE, 524824 on the BSE, and the ISIN is INE083D01012.
What was yesterday's closing price of Bal Pharma shares ?
Bal Pharma shares closed yesterday at ₹90.50 on NSE & ₹89.25 on BSE
How to buy Bal Pharma shares?
To buy Bal Pharma shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Bal Pharma shares on Holidays?
No, shares of Bal Pharma or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Bal Pharma shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Bal Pharma?
The PE and PB ratio of Bal Pharma is 22.48 and 1.73 respectively, as on 13 Aug, 2026, 15:29 IST.